Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Stomach Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Resectable Pancreatic Carcinoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Mesothelioma, Malignant 1Liposarcoma, Myxoid 1Liposarcoma 1Glioma 1Gastrointestinal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Basal Cell 1

Interventions

Fluorodeoxyglucose F18 2fluciclovine F-18 1atezolizumab 1X-Rays 1Radium-223 1RXDX-106 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Cell Count 1Aminophylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Transitional Cell × X-Rays × Clear all
NCT03039413 2025-08-22

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
20 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡